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Introduction  and aim:  There  is  a high  prevalence  of olfactory  dysfunction  in the general  population.
Several  causes  of  olfactory  dysfunction  have  been  reported  and  this  disorder  is  classically  divided  into
sinonasal  and  non-sinonasal-related  olfactory  dysfunction.  The  aims  of this  study  were  ﬁrstly,  to  evaluate
the frequency  of the  various  aetiologies  of  olfactory  dysfunction  in a population  of patients  with  non-
sinonasal-related  olfactory  dysfunction  and  secondly,  to  evaluate  the  degree  of olfactory  impairment
associated  with  these  various  aetiologies.
Material  and  methods:  We  retrospectively  reviewed  a cohort  of 496  patients  with non-sinonasal-related
olfactory  dysfunction.  The  aetiology  of the  olfactory  dysfunction  was  recorded  for  each  patient.  The
aetiology  was  determined  by  a complete  clinical  assessment,  including  medical  history,  complete
otorhinolaryngological  examination,  psychophysical  testing  of  olfactory  function,  recording  of  olfactory
event-related  potentials  and  brain  magnetic  resonance  imaging.  Six  groups  of patients  were  deﬁned
on  the  basis  of  the  aetiology  of  the  disease  and orthonasal  and  retronasal  psychophysical  olfactory
performances  were  evaluated  in each  group.
Results: Post-infectious  and  post-traumatic  aetiologies  were  the  most  common  causes,  representing
37.9%  and 33.1%  of patients,  respectively,  followed  by idiopathic  (16.3%),  congenital  (5.9%), toxic  (3.4%)
and  neurological  (3.4%)  olfactory  dysfunction.  Anosmia  was signiﬁcantly  more  frequent  in congeni-
tal  (93.1%)  and  post-traumatic  (62.8%)  olfactory  dysfunction,  whereas  hyposmia  was  more  frequent  in
the post-infectious  group  (59.6%).  Orthonasal  and  retronasal  olfactory  function  tests  were  signiﬁcantly
correlated  in  all groups  except  for the  congenital  group.
Conclusions:  The  data  of  this  study  conﬁrm  that  the  most  common  causes  of  non-sinonasal-related  olfac-
tory dysfunction  are  post-infectious  and  post-traumatic.  Post-infectious  olfactory  dysfunction  is mainly
observed  in middle-aged  women  and is  mainly  associated  with  hyposmia,  whereas  post-traumatic  olfac-
tory dysfunction  is  mainly  observed  in young  men  and  is  associated  with  a  high rate  of anosmia.
©  2013  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
The prevalence of olfactory dysfunction in the population
emains a subject of controversy. Although some authors have
eported a prevalence of 1 to 3% [1,2], a more recent study reported
 high prevalence of olfactory dysfunction, affecting almost 20% of
he general population, with anosmia and hyposmia rates of 4.7%
nd 16%, respectively [3].
∗ Corresponding author. Tel.: +0032 2 7641930.
E-mail addresses: philippe.rombaux@uclouvain.be,
hilippe.rombaux@orlo.ucl.ac.be (P. Rombaux).
http://dx.doi.org/10.1016/j.anorl.2013.03.006
879-7296/© 2013 Elsevier Masson SAS. All rights reserved.Olfactory dysfunction can be due to a large number of aeti-
ologies and can affect all levels of the olfactory system, from
the nasal fossae to central olfactory pathways. The most com-
mon  causes of olfactory dysfunction are inﬂammatory lesions of
the nasal sinuses, post-infectious disease and post-traumatic dis-
ease [4–6], as these three aetiologies account for two-thirds of all
patients with olfactory dysfunction. However, several other dis-
eases can also affect smell, such as a benign or malignant tumour
(hamartoma, esthesioneuroblastoma, meningioma, etc), neurolog-
ical disease (Parkinson’s disease, Alzheimer’s diseases, multiple
sclerosis), metabolic or endocrine disorders, exposure to toxins
(medications, neurotoxic drugs, chemical agents such as benzene,
formaldehyde or sulphuric acid), and anosmia can also be congen-
ital (either isolated or part of a more complex syndrome). In many
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ases, no cause can be formally identiﬁed and olfactory dysfunction
s then considered to be idiopathic.
Olfactory disorders due to sinonasal disease are common and
ell known to clinicians. Medical and surgical treatment generally
llows resolution of olfactory complaints.
In contrast, non-sinonasal-related olfactory dysfunction is less
ommon and less well known to clinicians. However, clinicians
ust be aware of these various diseases in order to establish an
etiological diagnosis, which determines the patient’s prognosis
7]. In some cases (neurological disease, metabolic disorder), the
iagnosis also allows treatment of the underlying disease. This is
articularly important, as it has now been clearly demonstrated
hat olfactory disorders severely alter the patient’s quality of life,
nd can be responsible for social disability, anxiety, depression as
ell as household accidents [8,9]. In the absence of effective treat-
ent for most these diseases, the patient must therefore be given
etailed information about the disease and the prognosis for recov-
ry.
The objective of this study was to evaluate the various aeti-
logies in a population of patients with non-sinonasal-related
lfactory dysfunction, the frequencies of these various aetiologies,
he clinical characteristics and the degree of olfactory impairment
ssociated with each aetiology.
. Material and methods
.1. Patients
This study was conducted on patients attending our centre
ith olfactory disorders as the main complaint between 2004 and
011. This population comprised 496 patients in whom olfactory
ysfunction was not related to sinonasal disease (allergy, acute
r chronic sinusitis, nasal sinus polyposis, benign or malignant
umours of the nasal fossae and paranasal sinuses). The aetiology
f olfactory dysfunction had been previously established on the
asis of medical history, complete ENT examination, psychophys-
cal assessment of smell, olfactory event-related potentials and
rain magnetic resonance imaging (comprising detailed examina-
ion of the olfactory bulbs). Six aetiological categories were deﬁned:
olfactory dysfunction was considered to be toxic when it occurred
following exposure to various medicinal products and industrial
chemicals;
the diagnosis of congenital anosmia was proposed when the
patient had no olfactory memory and on the basis of imaging
(aplasia or hypoplasia of the olfactory bulbs, decreased depth of
the olfactory sulcus);
neurological causes concerned patients with central nervous sys-
tem degenerative disease, sequelae of stroke or inﬂammatory
disease or intracranial tumour;
the diagnosis of post-traumatic olfactory dysfunction was based
on a clinical history of head injury chronologically related to onset
of olfactory dysfunction and on the basis of imaging (fragmented
and smaller olfactory bulbs, basal frontal contusions);
post-infectious olfactory dysfunction was diagnosed when olfac-
tory dysfunction occurred no more than six weeks after an upper
respiratory tract infection;
ﬁnally, olfactory dysfunction was considered to be idiopathic
when no cause could be identiﬁed after a thorough assessment.This cohort of patients was therefore divided into six distinct
roups: toxic, congenital, idiopathic, neurological, post-traumatic
nd post-infectious groups and the proportion of each aetiology
ithin the cohort was recorded.logy, Head and Neck diseases 131 (2014) 87–91
2.2. Psychophysical tests
The patient’s orthonasal and retronasal psychophysical olfac-
tory performances were evaluated in each group. Orthonasal
psychophysical performances were measured by the “Snifﬁn’ sticks
test” method [10]. In this test, felt-tip pens impregnated with vari-
ous odorant substances are presented in front of the patient’s nose.
This test comprises three aspects: determination of the detection
threshold (T for threshold), odour discrimination (D) and odour
identiﬁcation (I). Each subcategory is scored from 1 to 16, with a
maximum total score of 48 (TDI score). A total score less than 31
in subjects between the ages of 16 and 35 years, less than 28 in
subjects between the ages of 26 and 55 years and less than 19 in
subjects over the age of 55 years is considered to indicate hyposmia,
and a total score less than 15.5 is considered to indicate anosmia
[11]. Retronasal psychophysical performances (R) were evaluated
by application of 20 standardized odorant powders on the mobile
part of the patient’s tongue, and the patient was asked to identify
the odour from a multiple choice of four proposals. The maximum
total retronasal score is 20; a score less than 16–18 is suggestive of
hyposmia [12].
2.3. Statistics
Statistical analysis was  performed with SPSS 17.0 software (SPSS
Inc, Chicago, Ill). Data were tested by ANOVA with Bonferroni cor-
rection for multiple comparisons or nonparametric statistical tests,
including Kruskal–Wallis, Mann–Whitney and Chi2 tests. A P value
≤ 0.05 was  considered to be signiﬁcant. Correlations were deter-
mined by Spearman’s coefﬁcient.
3. Results
In this cohort of 496 patients, olfactory dysfunction was post-
infectious in 188 cases (37.9%), post-traumatic in 164 cases (33.1%),
idiopathic in 81 cases (16.3%), congenital in 29 cases (5.9%), toxic
in 17 cases (3.4%) and neurological in 17 cases (3.4%) (Table 1).
The mean age of the patients was  56 years in the post-infectious
group, 44 years in the post-traumatic group, 55 years in the
idiopathic group, 28 years in the congenital group, 58 years in
toxic group, and 67 years in the neurological group (Table 1).
Patients with congenital olfactory dysfunction were signiﬁcantly
younger than patients of the other groups (P < 0.001).  Patients
with post-traumatic olfactory dysfunction were also signiﬁcantly
younger (P = 0.002 versus the toxic group, P < 0.001 versus the
post-infectious, idiopathic and neurological groups). In contrast,
patients with neurological olfactory dysfunction were signiﬁcantly
older than the patients of all other groups, except for the toxic
group (P < 0.001 versus the post-traumatic and congenital groups,
P = 0.017 versus the idiopathic and post-infectious groups).
This cohort comprised 275 females (55.4%) and 221 males
(44.6%). A signiﬁcantly higher proportion of females compared to
males was  observed in the post-infectious group (74.4% females
vs. 26.6% males) (2 = 34.3, P < 0.001). In contrast, a signiﬁcantly
higher proportion of males compared to females was  observed in
the post-traumatic group (39.8% females vs. 61.2% males) (2 = 8.8,
P = 0.003). No signiﬁcant gender differences were observed in the
toxic (35.3% of females vs. 64.7% of males), neurological (58.8%
females vs. 41.2% males), congenital (62.1% females vs. 37.9% males)
and idiopathic groups (55.1% females vs. 44.9% males) (Table 1,
Fig. 1).Psychophysical scores were indicative of anosmia in 267
patients and indicative of hyposmia in 229 patients [11]. The
post-infectious olfactory dysfunction group comprised a signif-
icantly higher proportion of patients with hyposmia (n = 112)
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Table  1
Description of the various patient groups indicating the mean age and the age range in parentheses and the mean values for orthonasal (TDI) and retronasal (R) psychophysical
scores  with the 95% conﬁdence interval in parentheses.
Total Toxic Congenital Neurological Post-traumatic Post-infectious Idiopathic
Number of patients 496 17/496 (3.4%) 29/496 (5.9%) 17/496 (3.4%) 164/496 (33.1%) 188/496 (37.9%) 81/496 (16.3%)
Age  51 (7–90) 58 (46–69) 28 (7–75) 67 (40–85) 44 (15–90) 56 (27–88) 55 (21–89)
Gender 275 F
221 M
(1.24F/1 M)
6 F
11 M
(0.54F/1 M)
18 F
11 M
(1.64F/1 M)
10 F
7 M
(1.42F/1 M)
63 F
101 M
(0.62F/1 M)
134 F
54 M
(2.48F/1 M)
44 F
37 M
(1.19F/1 M)
Anosmic/
Hyposmic
267  A/229 H 10 A/7 H 27 A/2 H 11 A/6 H 103 A/61 H 76 A/112 H 40 A/41 H
TDI  (/48) 16.0 (15.4–16.7) 15.4 (11.1–22.8) 10.6 (9.4–11.8) 13.6 (9.4–17.9) 14.6 (13.5–15.5) 17.9 (17.2–19.3) 16.6 (14.9–18.1)
R  (/20) 7.6 (7.3–7.9) 7.9 (5.3–10.6) 6.4 (5.5–7.3) 6.5 (4.4–8.7) 6.7 (6.3–7.2) 8.3 (7.8–8.8) 8.3 (7.6–9.1)
TDI/R correlation
(Spearman)
r  = 0.579
P < 0.001
r = 0.838
P < 0.001
r = 0.103
P = 0.611
r = 0.615
P = 0.011
r = 0.442
P < 0.001
r = 0.593
P = 0.001
r = 0.615
P < 0.001
F: female; M:  male; A: anosmic; H: hyposmic.
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The mean age of patients with congenital anosmia (28 years)
may  appear somewhat surprising, but this age corresponded to the
mean age at the time of diagnosis, i.e., when the patient consultedig. 1. Sex distribution and severity of olfactory dysfunction according to aetiology
uch  higher proportion of males was observed in the post-traumatic group. B. The
f  hyposmia was higher in the post-infectious group.
han with anosmia (n = 76) (2 = 6.6, P = 0.01). In contrast, anos-
ia  was more frequently observed in the groups with congenital
27 anosmic patients vs. 2 hyposmic patients) (2 = 21.5, P < 0.001),
ost-traumatic (103 anosmic vs. 61 hyposmic) (2 = 10.8, P = 0.001),
oxic (10 anosmic vs. 7 hyposmic) (not signiﬁcant) and neurological
lfactory dysfunction (11 anosmic vs. 6 hyposmic) (not signiﬁcant),
hile a balanced distribution of anosmia (n = 40) and hyposmia
n = 41) was observed in the idiopathic olfactory dysfunction group
Table 1, Fig. 1).
Finally, a signiﬁcant correlation was observed between
rthonasal and retronasal scores in the overall cohort (r = 0.579,
 0.001) and in the various groups except for the congen-
tal group (post-infectious: r = 0.593, P = 0.001, post-traumatic:
 = 0.442, P < 0.001, idiopathic: r = 0.615, P < 0.001, neurological:
 = 0.615, P = 0.011; toxic: r = 0.838, P < 0.001; congenital: r = 0.103,
 = 0.611) (Table 1, Fig. 2).
. Discussion
The results of this study conﬁrm that post-infectious, post-
raumatic and, to a lesser extent, idiopathic causes are the most
ommon causes of non-sinonasal-related olfactory dysfunction, in
ine with the data reported in the literature [4–6]. However, com-
ared to previous studies, this study presents the advantage of
eing based on a large number of patients, all presenting non-
inonasal-related olfactory dysfunction.
Although a balanced sex ratio was observed for most aetiolo-
ies of olfactory dysfunction, post-infectious olfactory dysfunction
as found to mainly occur in middle-aged women, as previouslyuch higher proportion of females was observed in the post-infectious group and a
f anosmia was  higher in the post-traumatic and congenital groups, while the rate
reported in the literature [13,14]. In contrast, post-traumatic olfac-
tory dysfunction was  mainly observed in males [15], which can
probably be explained by the fact that high-risk occupations mostly
concern men, but also by the fact that men are more frequently
involved in road accidents and extreme sports.Fig. 2. Correlation between orthonasal and retronasal psychophysical scores. This
ﬁgure illustrates the correlation between the orthonasal psychophysical score (TDI)
and the retronasal psychophysical score (R) in the overall cohort.
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or the ﬁrst time. However, these patients generally reported a his-
ory of absence of smell observed for the ﬁrst time at the beginning
f adolescence. These patients rarely report olfactory complaints
uring childhood, probably because, as they have never had any
ense of smell, they only become aware of their deﬁciency much
ater in life, especially as children probably pay less attention to
heir sense of smell than adults.
As already mentioned, we observed a signiﬁcant correlation
etween orthonasal and retronasal psychophysical scores in these
atients [4,12], with the exception of the group of congenitally
nosmic patients. In a previous study [4], we suggested that
he absence of correlation in the group of congenitally anosmic
atients could be explained by the small number of subjects. How-
ver, no correlation was observed in the present study, despite
he larger number of patients included in this cohort. Another
xplanation could therefore be that the pathophysiology of con-
enital anosmia is radically different from that of acquired olfactory
ysfunction, as congenitally anosmic patients have never had a
unctioning olfactory system [16]. By analogy with other sensory
ystems, we can formulate the hypothesis that patients with con-
enital anosmia present cross-modal sensory compensations, as it
s well known that congenital sensory deprivation induces cross-
odal sensory compensation (e.g.: congenitally blind patients
resent enhanced auditory spatial attention capacities compared to
ealthy controls) [17,18]. It is also noteworthy that orthonasal and
etronasal olfactory pathways differ, as, unlike orthonasal olfaction
hich is perceived exclusively via the olfactory pathway (although
lso inﬂuenced by the visual system), retronasal olfactory per-
eption is not exclusively mediated via olfactory pathways, but
s also inﬂuenced by all other sensory modalities (taste, touch,
earing, proprioception, vision) integrated in the orbitofrontal cor-
ex [19]. Congenitally anosmic patients therefore also probably
resent cross-modal compensations, resulting in more devel-
ped tactile, gustatory and nociceptive sensory capacities than in
he normal population. As retronasal testing is performed with
ood powders placed in contact with the oral cavity, it is there-
ore possible that, in these patients, this test also reﬂects their
actile (e.g. coconut), gustatory (e.g. lemon) or trigeminal (e.g.
epper) capacities, which could therefore explain the absence
f correlation between orthonasal and retronasal psychophysical
cores.
An aetiology was identiﬁed in almost 85% of patients in this
ohort, which highlights the importance of performing a com-
lete clinical assessment in these patients. Although guided and
etailed clinical history-taking and a thorough otorhinolaryngo-
ogical examination can identify the aetiology in many cases, it is
ssential to assess olfactory function by means of psychophysical
ests, MRI  and, when feasible, olfactory event-related poten-
ials.
The advantages of psychophysical tests are that they have been
alidated on large series, they are reliable, can be easily performed
n the doctor’s room and are inexpensive [10]. However, they are
emi-objective tests, and can therefore be biased by the patient’s
ubjective response, which can constitute a major drawback in
he medicolegal setting (e.g. post-traumatic olfactory dysfunction).
bjective methods of evaluation are therefore particularly useful.
lfactory function can be evaluated objectively by recording olfac-
ory event-related potentials, a particularly useful technique in the
edicolegal setting, as a patient with a very low psychophysical
core, but high amplitude olfactory event-related potentials can be
uspected to be a simulator. However, this promising technique has
he disadvantage of purely dichotomous interpretation (present
r absent) and a fairly low signal-to-noise ratio when the signal
s analysed by classical averaging analysis techniques [20]. This
echnique also requires expensive equipment and is therefore not
idely available.logy, Head and Neck diseases 131 (2014) 87–91
MRI  can provide useful information in the assessment of olfac-
tory dysfunction. Firstly, brain MRI  can diagnose a neurological
cause of olfactory dysfunction in some cases (tumour, multiple scle-
rosis, etc.). MRI  images of the anterior part of the skull base and
olfactory bulb are also particularly useful for both diagnosis and
prognosis. For example, severe hypoplasia or aplasia of the olfac-
tory bulb and/or olfactory tract and decreased depth of the olfactory
sulcus suggest the presence of congenital anosmia [21]. In patients
with post-traumatic olfactory dysfunction, MR images must be
carefully examined for signs of a fragmented, reorganized olfac-
tory bulb and signs of cerebral contusion, especially in the basal
frontal region. The volume of the olfactory bulbs is also known to be
decreased in post-infectious, post-traumatic or idiopathic olfactory
dysfunction [13,22] and the volume of the olfactory bulbs is corre-
lated with olfactory function in these diseases [22]. Furthermore, it
has recently been demonstrated that the olfactory bulb could also
constitute a prognostic factor in patients with post-infectious or
post-traumatic olfactory dysfunction [23].
On the basis of this assessment, it will be possible, in the majority
of cases to:
• establish a diagnosis and provide the patient with detailed infor-
mation about his or her disease and propose treatment of any
underlying disease (e.g. metabolic or neurological disease);
• follow the course of olfactory dysfunction with respect to the
baseline psychophysical score of olfactory capacities;
• establish the prognosis for recovery.
A deﬁnite prognosis cannot be proposed at the present time, but
the prognosis is known to be more favourable in the presence of
partial olfactory dysfunction (hyposmia vs. anosmia) [7] and in the
presence of olfactory event-related potentials [24]. A total volume
of the olfactory bulbs less than 40 mm3 is associated with a poor
prognosis [23]. Age and gender are also important factors to be
taken into account, as the prognosis appears to be better in younger
patients and in females [7]. The predictive value of the aetiology and
duration of the disorders is still the subject of debate at the present
time [7].
This study only assessed quantitative olfactory dysfunction,
which can be easily measured by psychophysical tests. However,
when taking the clinical history, it is essential to ask the patient
about any qualitative disorders (parosmia, phantosmia). These
symptoms, which are difﬁcult to detect by psychophysical tests,
have a major impact and severely impair the patient’s quality of life.
Questionnaires have now been developed to evaluate the disability
induced by these qualitative disorders and should be systematically
submitted to patients consulting for olfactory complaints [8].
Finally, although effective medical and surgical treatments are
available for olfactory dysfunction related to sinonasal disease, no
effective treatments for non-sinonasal-related olfactory dysfunc-
tion are available at the present time. Many drugs have been tested
in patients with post-infectious olfactory dysfunction, but none
have been shown to be really effective at the present time. How-
ever, olfactory training appears to be a promising approach and
can be proposed to patients with post-infectious, post-traumatic
or idiopathic olfactory dysfunction [25]. As treatment can rarely
be proposed to these patients, it is essential to inform them about
the consequences of loss of smell on daily life, especially the con-
sequences on bodily hygiene and the detection of danger signs
(smoke, gas). The patient’s everyday life can be improved by appro-
priate advice (use of ﬁre detectors, cooking books adapted to
anosmic subjects, etc.). Finally, it must be kept in mind that not
only does olfactory dysfunction impair quality of life, but it can also
be associated with depressive disorders. Appropriate psychological
support should therefore be proposed in these patients.
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. Conclusion
The most common causes of non-sinonasal-related olfactory
ysfunction are post-infectious and post-traumatic. Post-infectious
lfactory dysfunction usually consists of hyposmia, mainly affect-
ng middle-aged women. Post-traumatic olfactory dysfunctions is
sually more severe (anosmia) and mainly affects young men. A
omplete clinical history and physical examination are essential
o establish an aetiological diagnosis. A complementary work-up,
ncluding psychophysical tests, olfactory event-related potentials
nd brain magnetic resonance imaging, should be proposed in these
atients to precisely determine the aetiology of the disease, deﬁne
he type of olfactory dysfunction and provide the patient with com-
lete information and a prognosis for recovery.
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